These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 82090)

  • 1. Prostacyclin can replace heparin in haemodialysis in dogs.
    Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
    Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of prostacyclin and heparin on hemodialyses in dogs.
    Gross M; Bush H; McTigue H; Hamburger RJ; Flamenbaum W
    Prostaglandins; 1981 Jun; 21(6):879-88. PubMed ID: 7027320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Lancet; 1980 Aug; 2(8188):219-22. PubMed ID: 6105392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
    Woods HF; Weston MJ; Bunting S; Moncada S; Vane J
    Artif Organs; 1980 Aug; 4(3):176-9. PubMed ID: 6998437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of heparin and prostacyclin/heparin infusion on platelet aggregation in hemodialyzed patients.
    Kuźniewski M; Sułowicz W; Hanicki Z; Kus J; Nowogrodzka-Zagórska M; Kostka-Trabka E; Bieroń K; Debińska-Kieć A
    Nephron; 1990; 56(2):174-8. PubMed ID: 2243573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
    Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
    Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-platelet action of intravenous infusion of prostacyclin in man.
    Gryglewski RJ; Szczeklik A; Nizankowski R
    Thromb Res; 1978 Aug; 13(2):153-63. PubMed ID: 358486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.